Morphine sulphate consumption by French drug users
Memo, OFDT, 16 p.
July 2014
The use of morphine sulphate outside of the scope of the therapeutic framework is not a new phenomenon. However, starting in 2000 and for a decade thereafter, such use appeared to be fairly controlled, geographically-contained and volatile over time. Since 2011 or so, there has been a rise in demand that is disparate, but geographically widespread.
Authors : Agnès Cadet-Taïrou, Michel Gandilhon
Download the PDF file (425 Ko)
Drugs in Europe
2021 EMCDDA European Drug Report
COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
